ALHC

Freeman Robert Thomas

Known title: Chief Financial OfficerCIK: 0001850414

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings. Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.

this person other insiders at ALHC

Transaction History

ALHC▼ Sell$121K
ALHC▼ Sell$118K
ALHC▼ Sell$70K
ALHC▼ Sell$233K
ALHC▲ Buy$0
ALHC▼ Sell$223K
ALHC▼ Sell$3K
ALHC▼ Sell$3.4M
ALHC▼ Sell$3.9M
ALHC▲ Buy$0
ALHC▼ Sell$409K
ALHC▼ Sell$436K
ALHC▼ Sell$54K
ALHC▼ Sell$351K
ALHC▼ Sell$473K
ALHC▼ Sell$100K
ALHC▼ Sell$123K
ALHC▼ Sell$104K
ALHC▼ Sell$174K
ALHC▼ Sell$1.3M
ALHC▼ Sell$86K
ALHC▼ Sell$48K
ALHC▼ Sell$16K
ALHC▼ Sell$100
ALHC▼ Sell$389K
ALHC▼ Sell$440K
ALHC▼ Sell$221K
ALHC▼ Sell$21K
ALHC▼ Sell$144K
ALHC▼ Sell$58K
ALHC▲ Buy$0
ALHC▼ Sell$21K
ALHC▼ Sell$32K
ALHC▼ Sell$85K
ALHC▼ Sell$14K
ALHC▼ Sell$314K
ALHC▼ Sell$318K
ALHC▼ Sell$314K
ALHC▲ Buy$0
ALHC▼ Sell$349K
ALHC▼ Sell$750K
ALHC▼ Sell$55K
ALHC▼ Sell$348K
ALHC▼ Sell$254K
ALHC▼ Sell$137K
ALHC▼ Sell$1K
ALHC▼ Sell$42K
ALHC▼ Sell$134K
ALHC▼ Sell$38K
ALHC▼ Sell$55K
ALHC▲ Buy$0
ALHC▼ Sell$1.7M
ALHC▼ Sell$446K

We use analytics to understand how market-wall is used. No personal data is sold.